OVID 13D FILING

Company

Ovid Therapeutics Inc.

Filed

March 1, 2019

Accession Number

0001768824-19-000004

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →